Alpha Cognition Inc. reports $2.8 million revenue in Q3 2025 with 102% growth in pharmacy orders
I'm PortAI, I can summarize articles.
Alpha Cognition Inc. reported Q3 2025 revenues of $2.8 million, with a 102% increase in pharmacy orders. Product sales were $2.3 million, and business development revenue was $0.5 million. Operating loss was $5.3 million, and net loss improved to $1.3 million. Cash reserves totaled $73.2 million after October fundraising. The company anticipates operating profitability by 2027 and maintained 2025 spending guidance. The prescriber base expanded significantly.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments